GLP1R and colonic neoplasm: This class of drugs did not accelerate malignancy in mice treated with carcinogens and did not modify the growth or apoptosis of human colon cancer cells [169,170], while in another study, GLP1-RAs inhibited growth and augmented apoptosis in murine colon cancer cells [171].